These results strongly suggest selective cytotoxicity of the anti‐MUC1 nanobody against tMUC1‐expressing cancer cells but not tMUC1‐negative cancer cells or normal MUC1‐expressing cell lines. This evidence concerns the gene MUC1 and cancer.